Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The upper extremity postthrombotic syndrome score: an international Delphi consensus study to determine the score's functional disability component

Autor: Ludo Schropp, Roos B. Cats, Robert J.C.M.F. de Kleijn, Eline S. van Hattum, Saskia Middeldorp, Mathilde Nijkeuter, Jan Westerink, Bart-Jeroen Petri, Gert J. de Borst, L. Schropp, R.B. Cats, R.J.C.M.F. de Kleijn, S. Black, D. Garcia, K. Meijer, M.R. Nijziel, E.M. Klappe, G. Geroulakos, C.H. van Ommen, M.J.E. van Rijn, J. Freischlag, M.J.H.A. Kruip, M.V. Huisman, M. Coppens, J.A.W. Teijink, S.K. Kakkos, G. Le Gal, P.E. Westerweel, M.L. Avila, L. Baumann Kreuziger, A.J. Ten Cate-Hoek, A.Y.Y. Lee, M.J. Koelemay, A. Srivastava, M.M.C. Hovens, Ç. Ünlü, F.A. Klok, J. Douketis, G. Stansby, K.A. Illig, R.W. Thompson, W.A. Bax, D. Poli, S.R. Kahn, E.S. van Hattum, S. Middeldorp, M. Nijkeuter, J. Westerink, B.J. Petri, G.J. de Borst

Publikováno v: Research and practice in thrombosis and haemostasis, 7(1):100051. Wiley-Blackwell Publishing Ltd
Research and Practice in Thrombosis and Haemostasis, 7, 1
Research and Practice in Thrombosis and Haemostasis, 7(1):100051. Wiley-Blackwell Publishing Ltd
in collaboration with the Upper Extremity PTS group 2023, ' The upper extremity postthrombotic syndrome score : an international Delphi consensus study to determine the score's functional disability component ', Research and practice in thrombosis and haemostasis, vol. 7, no. 1, 100051 . https://doi.org/10.1016/j.rpth.2023.100051
Research and Practice in Thrombosis and Haemostasis, 7

Contains fulltext : 291124.pdf (Publisher’s version ) (Open Access) BACKGROUND: In upper extremity thrombosis research, the occurrence of upper extremity postthrombotic syndrome (UE-PTS) is commonly used as the main outcome parameter. However, ther

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11f310abf4452627763b7ec4d7e8dd18
https://research.vumc.nl/en/publications/2f322cc8-ec49-43f5-9a75-30704732b156

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Diffuse alveolar hemorrhage as an early complication of alemtuzumab treatment: A case report of a multiple sclerosis patient and an overview of 14 cases

Autor: D. Zemel, Beatrijs H.A. Wokke, B.R.H. Drop, J.W.K. de Beukelaar, S. Dik, B.W. van Oosten, P.E. Westerweel, C.O. Martins Jarnalo

Publikováno v: Multiple Sclerosis and Related Disorders, 47:102614. Elsevier Inc.
Multiple Sclerosis and Related Disorders, 47:102614. Elsevier
Drop, B R H, Zemel, D, Wokke, B H A, van Oosten, B W, Dik, S, Martins Jarnalo, C O, Westerweel, P E & de Beukelaar, J W K 2021, ' Diffuse alveolar hemorrhage as an early complication of alemtuzumab treatment: A case report of a multiple sclerosis patient and an overview of 14 cases ', Multiple Sclerosis and Related Disorders, vol. 47, 102614 . https://doi.org/10.1016/j.msard.2020.102614

Alemtuzumab is effective in relapsing remitting multiple sclerosis (RRMS). Serious adverse events have led to a renewed safety reassessment by the European Medicines Agency (EMA), leading to an approval under strict conditions. We report a RRMS patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28607c94376fcb7683d8e51c250b5731
https://pure.eur.nl/en/publications/419e74cf-6003-406b-8db5-e7868ac6e376

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.